Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alisa Urbano

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Computers & Chemical Engineering|August 21, 2019
APT-MCMC, a C++/Python implementation of Markov Chain Monte Carlo for parameter identificationLi Ang Zhang, Alisa Urbano, Gilles Clermont, et al.
Frontiers in Medicine|June 6, 2022
Identification of Clinical Phenotypes in Septic Patients Presenting With Hypotension or Elevated LactateZachary T Aldewereld, Li Ang Zhang, Alisa Urbano, et al.
Journal of Virology|September 15, 2017
Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in ImmunityEricka Keef, Li Ang Zhang, David Swigon, et al.
Blood Advances|December 19, 2022
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myelomaTaiga Nishihori, James E Hoffman, Anne Huff, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Computers & Chemical Engineering|August 21, 2019
APT-MCMC, a C++/Python implementation of Markov Chain Monte Carlo for parameter identificationLi Ang Zhang, Alisa Urbano, Gilles Clermont, et al.
Frontiers in Medicine|June 6, 2022
Identification of Clinical Phenotypes in Septic Patients Presenting With Hypotension or Elevated LactateZachary T Aldewereld, Li Ang Zhang, Alisa Urbano, et al.
Journal of Virology|September 15, 2017
Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in ImmunityEricka Keef, Li Ang Zhang, David Swigon, et al.
Blood Advances|December 19, 2022
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myelomaTaiga Nishihori, James E Hoffman, Anne Huff, et al.
Pageof 1